Literature DB >> 33617886

The role of complement in brain injury following intracerebral hemorrhage: A review.

Katherine Holste1, Fan Xia2, Hugh J L Garton1, Shu Wan1, Ya Hua1, Richard F Keep1, Guohua Xi3.   

Abstract

Intracerebral hemorrhage (ICH) is a significant cause of death and disability and current treatment is limited to supportive measures to reduce brain edema and secondary hematoma expansion. Current evidence suggests that the complement cascade is activated early after hemorrhage and contributes to brain edema/injury in multiple ways. The aim of this review is to summarize the most recent literature about the role of the complement cascade after ICH. Primary literature demonstrating complement mediated brain edema and neurologic injury through the membrane attack complex (MAC) as well as C3a and C5a are reviewed. Further, attenuation of brain edema and improved functional outcomes are demonstrated after inhibition of specific components of the complement cascade. Conversely, complement also plays a significant role in neurologic recovery after ICH and in other neurologic disorders. We conclude that the role of complement after ICH is complex. Understanding the role of complement after ICH is essential and may elucidate possible interventions to reduce brain edema and injury.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain injury; Complement; Intervention; Intracerebral hemorrhage

Mesh:

Substances:

Year:  2021        PMID: 33617886      PMCID: PMC8119338          DOI: 10.1016/j.expneurol.2021.113654

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.620


  105 in total

Review 1.  Intracranial hemorrhage.

Authors:  Andrew M Naidech
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

Review 2.  Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins.

Authors:  M Griffiths; J W Neal; P Gasque
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

3.  Naturally occurring anti-band 3 antibodies have a unique affinity for C3.

Authors:  H U Lutz; M Nater; P Stammler
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 4.  New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies.

Authors:  Jaroslaw Aronowski; Christiana E Hall
Journal:  Neurol Res       Date:  2005-04       Impact factor: 2.448

5.  Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung.

Authors:  T Nakamura; B Vollmar; J Winning; M Ueda; M D Menger; H J Schäfers
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

6.  Generation of an activated form of human C5 (C5b-like C5) by oxygen radicals.

Authors:  W V von Zabern; D Hesse; R Nolte; Y Haller
Journal:  Immunol Lett       Date:  1987-02       Impact factor: 3.685

Review 7.  Complement in disease: a defence system turning offensive.

Authors:  Daniel Ricklin; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2016-05-23       Impact factor: 28.314

Review 8.  How sex and age affect immune responses, susceptibility to infections, and response to vaccination.

Authors:  Carmen Giefing-Kröll; Peter Berger; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  Aging Cell       Date:  2015-02-26       Impact factor: 9.304

Review 9.  The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke.

Authors:  Fenghui Ye; Hugh J L Garton; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2020-09-29       Impact factor: 6.800

10.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial.

Authors:  A David Mendelow; Barbara A Gregson; Elise N Rowan; Gordon D Murray; Anil Gholkar; Patrick M Mitchell
Journal:  Lancet       Date:  2013-05-29       Impact factor: 79.321

View more
  8 in total

Review 1.  Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage.

Authors:  Zhe Li; Yang Liu; Ruixue Wei; Suliman Khan; Ruiyi Zhang; Yan Zhang; Voon Wee Yong; Mengzhou Xue
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

Review 2.  Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

Authors:  Karin Hochrainer; Wei Yang
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

Review 3.  The Fate of Erythrocytes after Cerebral Hemorrhage.

Authors:  Fan Xia; Richard F Keep; Fenghui Ye; Katherine G Holste; Shu Wan; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2022-01-23       Impact factor: 6.800

4.  Curcumin Nanoparticles Inhibiting Ferroptosis for the Enhanced Treatment of Intracerebral Hemorrhage.

Authors:  Cong Yang; Mengmeng Han; Ruoyu Li; Tongkai Chen; Yousheng Mo; Ligui Zhou; Ying Zhang; Lining Duan; Shiyu Su; Min Li; Qi Wang
Journal:  Int J Nanomedicine       Date:  2021-12-14

5.  Elevated Serum Complement C1q Levels After Traumatic Brain Injury [Letter].

Authors:  Wellingson Silva Paiva; Josimar Ortiz; Robson Luis Amorim
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-04       Impact factor: 2.570

Review 6.  Role of Eryptosis in Hemorrhagic Stroke.

Authors:  Mei Fang; Fan Xia; Yuqi Chen; Yuke Shen; Lu Ma; Chao You; Chuanyuan Tao; Xin Hu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

7.  "Rogue" [DEspR+CD11b+] neutrophil subset correlates with severity in spontaneous intracerebral hemorrhage.

Authors:  Victoria L M Herrera; Courtney E Takahashi; Mai Q Nguyen; Julie Z Mosaddeghi; Ridiane Denis; David M Greer; Nelson Ruiz-Opazo
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

Review 8.  Molecular, Pathological, Clinical, and Therapeutic Aspects of Perihematomal Edema in Different Stages of Intracerebral Hemorrhage.

Authors:  Chao Jiang; Hengtao Guo; Zhiying Zhang; Yali Wang; Simon Liu; Jonathan Lai; Tom J Wang; Shize Li; Jing Zhang; Li Zhu; Peiji Fu; Jiewen Zhang; Jian Wang
Journal:  Oxid Med Cell Longev       Date:  2022-09-17       Impact factor: 7.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.